Case-Based CME Shares Latest CLL and MCL Research and Outcomes

The National Marrow Donor Program/Be The Match is now offering a new CME activity for hematologists/oncologists who treat CLL or MCL. This program was originally presented at a live symposium preceding the 2013 ASH (American Society of Hematologists) Annual Meeting. 

A Case-Based Approach to CLL and MCL: Novel Therapies and Transplant Options explores challenging questions with evolving therapies for patients with CLL and MCL, such as:

  • What is the risk-adapted sequence for treatment of CLL?
  • Which CLL patients can benefit from new therapies alone or followed by hematopoietic cell transplantation (HCT)?
  • What are the optimal therapeutic approaches for MCL using standard agents, novel approaches and HCT? 

Faculty include:

  • Thomas J. Kipps, M.D., Ph.D., Moores Cancer Center, University of California-San Diego, La Jolla, Calif.
  • Peter Dreger, M.D., University of Heidelberg, Heidelberg, Germany
  • Ajay Gopal, M.D., University of Washington, Seattle, Wash.
  • Julie Vose, M.D., MBA, University of Nebraska Medical Center, Omaha, Neb.
  • Willis Navarro, M.D. (moderator), National Marrow Donor Program/Be The Match, Minneapolis, Minn. 

Access the CME activity.